15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
49
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH

Jagiellonian University Medical College
18
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.

Institute of Organic Synthesis
17
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.

University of Siena
3
Cyclic analogs of galanin and neuropeptide Y by hydrocarbon stapling.

University of Utah
17
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.

University of Utah
22
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.

University of Utah
38
Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.

The Scripps Research Institute
8
Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.

University of Utah
9
New cyclic tetrapeptides from Nonomuraea sp. TA-0426 that inhibit glycine transporter type 1 (GlyT1).

Taisho Pharmaceutical
10
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof

Georgetown University
47
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists

Ogeda
24
5,5-bicyclic oxazole orexin receptor antagonists

Merck Sharp & Dohme
28
Thienopyranones as kinase and epigenetic inhibitors

Signal Rx Pharmaceuticals
77
Identification of a potent new chemotype for the selective inhibition of PDE4.

Nih
25
Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.

Washington University